CD44 and breast carcinoma: snoRNA chips (Oebiotech, Shanghai, China) included 248 snoRNAs that were employed to investigate the differential snoRNAs expression between BCCs (breast cancer cells) and BCSCs, which revealed that SNORA38 was significantly overexpressed in CD44+CD24− subgroup (Figure S1).